Pec Infiltration With Liposomal Bupivacaine for Breast Surgery
Status:
Recruiting
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare pain control after breast surgery using either
liposomal bupivacaine or bupivacaine when infiltrated during an ultrasound guided pectoralis
1 and 2 block. Both medications, liposomal bupivacaine and bupivacaine, are standard of care
in these types of surgeries.
Phase:
Phase 4
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute